The quest for alternative drugs to the well-known cisplatin and its derivatives, which are still
used in more than 50% of the treatment regimes for patients suffering from cancer, is highly …

This review focuses on cytotoxic rhenium compounds in terms of IC 50 values, their mode of
action in biological systems and their status in clinical trials. Biological studies of different …

In the recent years, organometallic compounds have become recognized as promising anti-
cancer drug candidates. While radioactive 186/188Re compounds are already used in …

Our work has shown that certain ruthenium (II) arene complexes exhibit promising
anticancer activity in vitro and in vivo. The complexes are stable and water-soluble, and their …

This review describes the photophysics and photochemistry of various diimine rhenium (I)
tricarbonyl complexes. The exceptionally diverse photophysical behavior of these …

Over the recent years, several Re (I) organometallic compounds have been shown to be
toxic to various cancer cell lines. However, these compounds lacked sufficient selectivity …

This review describes recent advances in the photochemistry of complexes of the element
rhenium. It covers not only fundamental chemistry but the recent applications of these …

Combination therapy targeting both tumor growth and vascularization is considered to be a
cornerstone for colorectal carcinomas (CRC) treatment. However, the major obstacles of …

We report here the design of the first class of luminescent biotinylation reagents derived from
rhenium (I) polypyridine complexes. These complexes [Re (N− N)(CO) 3 (py-biotin …

A series of luminescent cyclometalated iridium (III) polypyridine indole complexes,[Ir (N∧ C)
2 (N∧ N)](PF6)(HN∧ C= 2-phenylpyridine (Hppy), N∧ N= 4-((2-(indol-3-yl) ethyl) …